With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.
General procedure: [Cu(MeCN)4]PF6 (75 mg, 0.20mmol) was added to dppp (82 mg, 0.20mmol) in 5mL of dichloromethane. Then, bpy (32 mg, 0.20mmol) was added and the solution immediately changed to yellow. The reaction mixture was stirred for 30 min at room temperature. Diethyl ether was added to the solution to precipitate the product as a yellow solid, which was filtered and washed with diethyl ether: yield, 126 mg (0.162mmol, 81percent)., 17217-57-1
As the paragraph descriping shows that 17217-57-1 is playing an increasingly important role.
Reference£º
Article; Nishikawa, Michihiro; Tsubomura, Taro; Bulletin of the Chemical Society of Japan; vol. 87; 8; (2014); p. 912 – 914;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI